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Abstract: Background: Research on heart rate variability has increased in recent years and the
temperature has not been controlled in some studies assessing repeated measurements. This study
aimed to analyze how heart rate variability may change based on environmental temperature during
measurement depending on parasympathetic and sympathetic activity variations. Methods: A total
of 22 volunteers participated in this study divided into an experimental (n = 12) and control group
(n = 10). Each participant was assessed randomly under two different environmental conditions for
the experimental group (19 ◦C and 35 ◦C) and two identical environmental conditions for the control
group (19 ◦C). During the procedure, heart rate variability measurements were carried out for 10 min.
Results: Significantly changes were observed for time and frequency domains as well as Poincaré
plot variables after heat exposure (p < 0.05). These findings were not observed in the control group,
whose conditions between measurements did not change. Conclusions: The reduction of heart rate
variability due to exposure to hot conditions appears to be produced mostly by a parasympathetic
withdrawal rather than a sympathetic activation. Therefore, if consecutive measurements have to be
carried out, these should always be done under the same temperature conditions.
Keywords: sympathetic; parasympathetic; heat; cold; autonomic
1. Introduction
Heart rate variability (HRV) was initially used merely for clinical purposes [1]. How-
ever, in recent years, there has been a growing interest in HRV research and its use. HRV has
generally been used for autonomic nervous system assessment [2–4], myocardial infarction
related assessment [5–7], neuropathy associated with diabetes mellitus [8,9], myocardial
dysfunction [10,11], and trait anxiety [12], among others. Researchers have suggested that
exercise was able to modify autonomic balance [13,14], and at present, HRV is being used
even for training control [15,16] and performance estimation [17,18].
Not only does HRV decrease with age, but several variables may also influence
changes in HRV. The standard deviation of RR intervals (SDNN), the square root of
the mean squared differences of successive RR (RMSSD), and the proportion of interval
differences of successive RR intervals greater than 50 ms (pNN50) decrease with age [19].
This is similar for low- and high-frequency power [20] and Poincaré plot variables, such
as the standard deviation of instantaneous beat-to-beat RR interval variability (SD1) [21].
Gender is presented as another variable that influences HRV, observing significantly lower
values for SDNN and standard deviation of consecutive 5 min RR values in women under
50 years of age [19]. Men show significantly higher values in RMSSD and pNN50 when
compared to women at the ages of 29 and above [20], and having no significance in gender
from the age range of 50 to 99 years old. Physical fitness appears as another determinant
of HRV, observing that subjects with lower values of maximal oxygen consumption also
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present lower values of high-frequency power and SD1 [21]. Physically active people also
present higher values for total power and lower values for high frequency (HF) indexes [22].
Recent findings have been described to assess autonomic balance even more accurately [23].
It is known that hotter environments increase mortality and morbidity if compared
to normal conditions. Syncope and cardiovascular collapse may occur as a consequence
of affected central hypovolemia by heat stress, which may also endanger tissues as a lack
of oxygenation is provoked by changes in blood flow [24]. The main mechanisms for this
heat dissipation in humans are supported by increased skin and skeletal muscle blood flow
and sweat secretion [25].
Even though several studies have carried out HRV measurement, many of them have
not reported if these measurements were taken under the same temperature conditions,
considering that the heat and cold stress directly affect many physiological variables [26].
On the topic of whether it is important to take into account the temperature for the
sympathetic-vagal balance assessment, some previous studies have described how tem-
perature affects HRV depending on the ambient temperature of the season but not during
the measurement [27]. Additionally, some articles have studied the effect of different
temperatures on HRV during the measurement [28–30], but not all of them have analyzed
time domain, frequency domain, and Poincaré plot variables. Thus, this study aimed to
analyze how heart rate variability may change based on the environmental temperature
during measurements, depending on the parasympathetic and sympathetic variations.
2. Materials and Methods
A total of 22 physically active (11 men and 11 women), healthy, and non-smoker indi-
viduals were randomly divided into an experimental group (EG) and control group (CG).
Table 1 shows the characteristics of both groups. All subjects voluntarily participated in
this study and signed an informed consent form before the beginning of the measurements.
The study was conducted according to the guidelines of the Declaration of Helsinki and
approved by the ethics committee of the Catholic University of Murcia (reference 6714).
Table 1. Sample characteristics.
Experimental Group (n = 12) Control Group (n = 10)
Outcome M SD M S
Age (years) 25 3 24 3
Height (cm) 174 7 176 8
Weight (kg) 68 11 71 9
Body mass index (kg·m2) 22.4 2.2 22.9 1.4
Each participant attended the laboratory for two consecutive days at the same time of
the day (15:00). During the first visit, anthropometric measurements were assessed (height
and weight) and the first heart rate variability measurement was performed immediately
after anthropometric measurements. Body mass and stretch stature were assessed using
a scale with stadiometer Seca 720 (Hamburg, Germany) with a precision of 100 g and
1 mm, respectively. The succeeding day, participants went to the laboratory again for
the second heart rate variability measurement. All participants were requested to avoid
any high-intensity activity, to avoid eating copiously and refrain from alcohol and coffee
consumption 24 h before the first measurement until the end of the second measurement.
Additionally, none of the women were measured during the menstrual period.
HRV measurements consisted of 10 min in a lying down position under two different
environmental conditions, hot environment (HE) at 35 ◦C and cool environment (CE) at
19 ◦C for EG and two exposures to a 19 ◦C environment for the CG. The temperature
selected for each measurement was reached before each participant came to the laboratory.
Relative humidity during the measurements remained constant to avoid it as an external
factor affecting the HRV measurements. The relative humidity constant value was 51%.
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Ambient temperature and relative humidity were assessed before and during the HRV
measurements using an environmental meter Kestrel 5000 (Minneapolis, MN, USA). The
temperature variations were in a range of ±0.4 ◦C and the relative humidity was in a range
of ±0.3%. Individuals wore shorts and a sports shirt and did not wear any shoes or socks.
The order of each trial was randomly assigned. Subjects wore a heart rate sensor Polar H7
(Kempele, Finland) to assess beat-to-beat recordings during the trial. Participants rested
in lying position 10 min before the beginning of the test to ensure that resting HR was
reached.
Further variable calculation was undertaken using the software Kubios HRV version
3.0. This software was also used to apply low threshold filters to remove artifacts; only
when artifacts appeared, a filter was used. Time domain, frequency domain, and Poincare
plot variables were retrieved. An analysis of data was done in a 5-min interval and two
different HRV analyses were assessed for each person and trial. Measuring was done from 0
to 5 min and from 5 to 10 min, as recommended [31]. The variables analyzed were the mean
R-R interval time (RR), the standard deviation of all RR intervals (SDNN), the square root
of the mean squared differences of successive RR intervals (RMSSD), and the number of
interval differences of successive RR intervals greater than 50 ms (NN50) and its proportion
(pNN50) for time domain variables. Fast Fourier Transform (FFT) was used to calculate the
spectral components of the frequency domain. Low-frequency power (0.04–0.15 Hz), high-
frequency power (0.15–0.4 Hz), and total power (0.04–0.4 Hz) components were calculated
as integrals of the respective power spectral density curve. These variables were expressed
in natural logarithm transformed values (LFln, HFln, and TPln). Simultaneously, the
LF/HF ratio was calculated, and LF and HF were expressed in normalized units to study
the balanced behavior of sympathetic and parasympathetic nervous systems (LFnu, HFnu).
Geometric pattern variables as the HRV triangular index and the triangular interpolation
of RR interval histogram and very low-frequency power were not calculated due to the
short time of the HRV measurement. Furthermore, the Poincaré plot-derived variables,
such as the standard deviation of the instantaneous beat-to-beat RR interval variability
(SD1), the standard deviation of continuous long-term R-R interval variability (SD2), and
the SD2/SD1 ratio, were calculated. Moreover, to assess the cardiac sympathetic tone, we
calculated the stress score (SS), which is calculated through “SS = 1000 ∗ 1/SD2” [23] as
the SD2 behavior has been shown to be inverse to the sympathetic activity [23]. Finally,
to assess the sympathetic-vagal balance, we calculated the sympathetic/parasympathetic
ratio (S/PS) through the relation between SD1 (parasympathetic tone) and SS (sympathetic
tone) [23].
Statistical analyses were conducted with IBM statistics SPSS v20.0 software (SPSS Inc.,
Chicago, IL, USA). A Shapiro–Wilk test was used for testing the normality of the data and
a two-way analysis of variance was used to investigate the main effects and the interaction
between the group factor (experimental vs. control) and the temperature factor (19 ◦C vs.
35 ◦C) as well as for the interaction between the group and temperature factor. A Bonferroni
post-hoc test was performed and the eta squared partial (η2p) was calculated to assess
the differences and effect size of the comparisons. A level of p ≤ 0.05 was set to indicate
statistical significance and effect sizes were set as small; η2p < 0.13, medium; η2p < 0.26,
and large; η2p > 0.26. Results are expressed as mean values ± standard deviation.
3. Results
We did not observe any difference between the first and last 5 min of measurements in
any of the variables assessed during the 19 ◦C exposure (p > 0.05). No significant differences
were found between EG and CG (p > 0.05) for any HRV variable, thus demonstrating the
homogeneity of the sample in both groups.
Tables 2 and 3 show the data for the assessment comparing 19 ◦C and 35 ◦C during
the first and last 5 min, respectively. Both tables show the pair comparisons as well as
the ANOVA interactions for the temperature and group effect as well as the interaction
Group*temperature effect.
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Table 2. Differences on heart rate variability depending on ambient temperature in experimental and control groups during
first 5 minutes of measurement.
ANOVA (F, p, η2p)
19 ◦C 35
◦C EG
19 ◦C CG Temperature Effect Group Effect Group*Temperature Effect
Outcome Group M SD M SD p F p η2p F p η2p F p η2p
RR
EG 1066.44 184.00 876.17 326.35 0.004
13.157 0.002 0.409 0.015 0.905 0.001 3.848 0.065 0.168CG 982.28 177.69 996.61 159.77 1
SDNN
EG 75.43 21.80 64.25 20.73 0.333
0.025 0.876 0.001 1.224 0.282 0.061 2.34 0.143 0.11CG 71.43 21.13 73.90 21.54 0.258
RMSSD
EG 76.14 28.92 52.85 29.46 0.096
0.38 0.545 0.2 0.087 0.771 0.005 3.255 0.087 0.146CG 60.74 22.37 61.18 26.74 0.422
pNN50 EG 45.74 18.90 28.43 22.26 0.021 2.338 0.143 0.11 0.612 0.444 0.031 3.72 0.069 0.164CG 38.76 17.20 37.35 27.75 0.785
LFln (ms2)
EG 7.14 0.66 6.95 0.70 0.449
0.051 0.824 0.003 0.06 0.81 0.003 1.671 0.212 0.081CG 6.89 0.77 6.85 0.84 0.307
LFnu
EG 44.35 21.43 52.60 18.58 0.049
0.7 0.413 0.036 1.154 0.296 0.057 3.593 0.073 0.159CG 56.49 17.60 50.97 21.68 0.473
HFln
(ms2)
EG 7.4 0.75 6.82 0.89 0.032
0.179 0.677 0.009 1.495 0.236 0.073 4.034 0.059 0.175CG 6.67 0.89 6.72 1.38 0.287
HFnu
EG 55.63 21.44 47.20 18.36 0.049
0.782 0.388 0.04 1.172 0.293 0.058 3.68 0.07 0.162CG 43.38 17.60 48.90 21.69 0.484
TPln
EG 8.38 0.50 8.06 0.61 0.233
0.001 0.98 <0.001 0.007 0.932 <0.001 2.981 0.1 0.136CG 6.64 1.79 6.51 1.55 0.241
LF/HF
EG 1.30 1.72 1.68 1.95 0.281
0.985 0.333 0.049 0.214 0.649 0.011 0.292 0.595 0.015CG 1.94 0.59 1.53 0.57 0.758
SD1
EG 53.95 20.48 40.20 18.62 0.095
0.380 0.545 0.02 0.086 0.773 0.004 3.268 0.087 0.147CG 43.04 15.85 49.00 37.37 0.421
SD2
EG 91.08 26.65 81.07 24.30 0.491
0.15 0.703 0.008 1.665 0.212 0.081 1.842 0.191 0.088CG 91.46 29.72 89.93 22.93 0.243
SD2/SD1
EG 1.82 0.58 2.19 0.59 0.04
3.153 0.092 0.142 1.503 0.235 0.073 1.597 0.222 0.078CG 2.96 2.09 2.21 0.69 0.728
SS
EG 10.97 2.62 13.32 3.83 0.187
0.511 0.483 0.026 0.91 0.352 0.046 1.375 0.255 0.067CG 13.28 3.34 12.92 3.81 0.755
S/PS
EG 0.23 0.12 0.43 0.27 0.045
1.852 0.189 0.089 0.052 0.822 0.003 2.566 0.126 0.119CG 0.32 0.30 0.50 0.42 0.87
HR: Heart rate; SDNN: Standard deviation of consecutive R-R intervals; pNN50: relative value of consecutive intervals that differ
by more than 50 ms; RMSSD: root mean square of successive differences of consecutive R-R intervals; HFln: High-frequency power
based on its natural logarithm; LFln: Low-frequency power based on its natural logarithm; HFnu: High-frequency power in normalized
units; HFnu: High-frequency power in normalized units; LF/HF: Ratio between low-and high-frequency power; SD1: the standard
deviation of instantaneous beat-to-beat interval variability; SD2: continuous long-term R/R interval variability; SS: Stress Score; S/PS:
sympathetic-parasympathetic ratio.
Table 3. Differences on heart rate variability depending on ambient temperature in experimental an control groups during
last 5 minutes of measurement.
ANOVA (F, p, η2p)
19 ◦C 35
◦C EG
19 ◦C CG Temperature Effect Group Effect Group*Temperature Effect
Outcome Group M SD M SD p F p η2p F p η2p F p η2p
RR
EG 1078.84 174.80 932.56 128.32 <0.001
17.093 0.001 0.474 0.08 0.78 0.004 4.127 0.056 0.178CG 1018.06 127.96 1048.88 112.37 0.163
SDNN
EG 76.42 21.54 65.52 20.47 0.932
0.348 0.562 0.018 2.383 0.139 0.111 0.503 0.487 0.026CG 71.83 21.67 74.02 22.32 0.381
RMSSD
EG 79.38 32.51 52.37 26.70 0.042
0.58 0.456 0.03 0.123 0.73 0.006 3.62 0.072 0.16CG 61.50 33.54 61.45 29.44 0.44
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Table 3. Cont.
ANOVA (F, p, η2p)
19 ◦C 35
◦C EG
19 ◦C CG Temperature Effect Group Effect Group*Temperature Effect
Outcome Group M SD M SD p F p η2p F p η2p F p η2p
pNN50 EG 46.72 17.64 27.64 18.07 0.019 3.395 0.081 0.152 0.138 0.714 0.007 2.882 0.106 0.132CG 39.77 23.16 37.57 20.81 0.921
LFln (ms2)
EG 7.08 0.74 6.95 0.63 0.655
0.546 0.469 0.028 0.233 0.635 0.012 0.013 0.912 0.001CG 6.84 0.79 6.84 0.64 0.563
LFnu
EG 41.70 18.97 57.05 19.47 0.026
1.876 0.187 0.09 0.041 0.842 0.002 3.821 0.065 0.167CG 58.25 15.95 51.99 18.03 0.691
HFln
(ms2)
EG 7.44 0.75 6.64 0.89 0.038
1.86 0.189 0.089 0.422 0.524 0.022 1.888 0.185 0.09CG 6.47 1.15 6.72 1.03 0.994
HFnu
EG 58.22 18.98 42.89 19.46 0.026
1.865 0.188 0.089 0.044 0.836 0.002 3.841 0.065 0.168CG 41.65 15.85 47.84 18.03 0.686
TPln
EG 8.51 0.55 8.16 0.66 0.156
1.903 0.184 0.091 0.42 0.525 0.022 0.434 0.518 0.022CG 6.65 1.03 6.78 0.84 0.624
LF/HF
EG 1.04 1.24 1.82 1.31 0.47
0.5 0.488 0.026 <0.001 0.988 <0.001 2.505 0.13 0.116CG 1.77 0.36 1.57 0.50 0.493
SD1
EG 56.24 23.04 37.08 18.92 0.042
0.583 0.455 0.03 0.124 0.729 0.006 3.625 0.072 0.16CG 43.56 23.76 43.53 20.83 0.44
SD2
EG 91.66 23.08 83.95 25.63 0.473
0.211 0.651 0.011 0.203 0.657 0.011 0.303 0.588 0.016CG 90.92 31.15 87.92 24.84 0.95
SD2/SD1
EG 1.75 0.47 2.54 0.79 0.048
2.924 0.104 0.133 0.034 0.856 0.002 5.062 0.037 0.21CG 2.29 0.49 2.23 0.61 0.238
SS
EG 13.32 3.83 12.89 3.65 0.337
1.311 0.266 0.065 0.002 0.962 <0.001 0.046 0.833 0.002CG 13.65 3.31 12.72 3.36 0.528
S/PS
EG 0.25 0.15 0.47 0.35 0.041
3.681 0.07 0.162 0.257 0.618 0.013 0.463 0.504 0.024CG 0.38 0.07 0.37 0.07 0.403
HR: Heart rate; SDNN: Standard deviation of consecutive R-R intervals; pNN50: relative value of consecutive intervals that differ
by more than 50 ms; RMSSD: root mean square of successive differences of consecutive R-R intervals; HFln: High-frequency power
based on its natural logarithm; LFln: Low-frequency power based on its natural logarithm; HFnu: High-frequency power in normalized
units; HFnu: High-frequency power in normalized units; LF/HF: Ratio between low-and high-frequency power; SD1: the standard
deviation of instantaneous beat-to-beat interval variability; SD2: continuous long-term R/R interval variability; SS: Stress Score; S/PS:
sympathetic-parasympathetic ratio.
4. Discussion
The main findings of this study were that not only do time domain variables signifi-
cantly change as a consequence of temperature, but the frequency domain and Poincare
plot variables are also affected. The ambient temperature effects on HRV were equal
between the first and last 5 min of measurement. Moreover, these differences did not
appear in the CG after performing both measurements in the same conditions. These
variations of HRV were higher in parasympathetic-related variables than in increments of
sympathetic-related variables.
Our results were similar to those recently revealed by other researchers, who observed
that hotter environments significantly reduced SDNN and RMSSD values [32]. On the
contrary, we did not observe the differences between CE and HE in SDNN values as shown
in previous research [28], in which an absence of significant differences on SDNN can be
seen when comparing a normal environment to a HE, observing significantly lower RR
intervals during HE. Additionally, pNN50 was always lower during heat exposure. The
standards of measurement, physiological interpretation, and clinical use [31] recommended
not to use NN50 and pNN50 because of their low statistical properties. Instead of these
variables, it is recommended to use RMSSD, which also decreases as a consequence of
heat exposure. However, low values of pNN50 have typically been used as a prognostic
indicator of chronic heart failure and myocardial infarction, as well as SDNN [5,33,34].
The RMSSD is the most commonly used variable in HRV to assess the autonomic nervous
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system activity, and our results have demonstrated that higher temperatures induce a
greater parasympathetic withdrawal during resting position. This phenomenon shows
how higher temperatures may behave as an external event which may affect real values
if several measurements have to be undertaken during the time. Further research should
study this effect not only during resting position but also during exercise and post-exercise
recovery.
Other studies determined that under different temperature conditions, LFnu showed
higher values during hot conditions, but similar results were not present when comparing
normal and cold conditions [29,30]. Conversely, HFnu presented lower values during
HE, revealing no differences between cold and normal conditions [29,30]. These results
were in agreement with our findings concerning LFnu, showing an increment during heat
exposure. Our results also showed decreases in HFnu due to higher temperature exposure.
These changes in LFnu and HFnu indicate that the proportion of the sympathetic-vagal
activation is altered by high temperatures [5,35]. We have already mentioned that HF has a
relationship with parasympathetic activity; however, LF has no relationship with sympa-
thetic activity, and therefore, we do not interpret LFnu as a variable of sympathetic activity.
On the other hand, LFnu can be interpreted as the inverse of parasympathetic activity, since
a higher value of HFnu will result in a lower value of LFnu. Significantly lower values were
observed in absolute values instead of natural logarithm transformed values for TP, very
low frequency (VLF), LF, and HF comparing hot and normal conditions [28,30]. Although
significantly higher values were described for LF/HF in a hotter environment in a previous
study [30], the effect of temperature on LF/HF was not detected in our data. Moreover,
significantly higher values were found for HFln during heat exposure; these differences
did not appear in the CG. We did not assess VLF due to the low validity in short-term
measurements [31]. Heat exposure provoked reductions of HFln, which means that the
frequency domain balance is altered by temperature. Since HRV variables have commonly
been used for training load and control, with HF being more interesting [15–18,36], athletes
and coaches should take into account that each HRV assessment must be undertaken in
the same temperature conditions. This could be a challenge for individual or team sports,
where the athlete’s training load is controlled by HRV, and competing in different environ-
ments with varying hot and cold temperatures. In these cases, environmental variables
may produce misleading data.
Previous research showed that after parasympatholytic infusion, SD1 and SD2 started
to decrease, and it approached closer to zero the more atropine was infused [37], showing
the direct relationship between SD1 and parasympathetic activation. Since heat exposure
reduces SD1 values, measuring HRV in changing conditions would make HRV analysis
ineffective for the control of vagal modulation of HR; this effect does not require SD1
calculation—calculating RMSDD is enough, since both variables are identical [38]. A
previous investigation revealed that after atropine infusion and during exercise, SD2/SD1
values increased similarly to those reported in the present study under heat exposure [37].
In previous research, the SD2/SD1 ratio was shown to not be as clear as an indicator of
autonomic balance [23]; our results agree with that because it was not stable from CE5 to
HE5. To avoid this lack of stabilization, the SS and S/PS ratio were previously defined [23],
showing that the inverse of SD2 has a direct relationship to sympathetic activity, and
thus, the ratio S/PS (SS/SD1) may give us information about the overlap of sympathetic
activation over parasympathetic in our measurements. SS did not change due to heat
exposure, showing that sympathetic activity is not significantly increased. These new
indexes show a greater relationship with autonomic balance variables than the SD2/SD1
ratio. This means that higher temperature produces a sympathetic activation assessed
through Poincare plot variables of HRV.
The main interest in using lesser-known variables such as SS is because they have been
created specifically to represent sympathetic activity. While it is true that other HRV-related
variables have traditionally been used to control sympathetic activity such as LF or the
LF/HF ratio, in recent years, a low relationship of sympathetic activity and these variables
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has been demonstrated. This is why a new perspective has been opened up to quantify the
sympathetic variant using variables created specifically for this purpose, such as SS, and
the ratio between SS and the already known variables for quantifying the parasympathetic
side, such as SD1 or the identical RMSSD.
An interesting fact observed in the present work is that during the second 5-min section
of heat exposure, HRV is reduced with respect to the first section. This seems to indicate
that longer heat exposure may still cause greater parasympathetic depletion. It might be
interesting for future research to analyze how HRV varies as a function of heat exposure
time and whether a stable plateau is reached as a function of different temperatures.
Considering that the sample in this study was not acclimatized to heat, the influence
of temperature on the organism must have triggered an excitability of the ANS, causing an
increase in blood flow that would subsequently translate into a significant increase in HR.
These changes in HR, together with the buffering of heat by the ANS through blood flow,
appear to be responsible for the significant changes observed in HRV with heat exposure.
The data analyzed in this study are coherent as increments in heart rate during heat
exposure are related to a decrease in parasympathetic effects [39,40] and were previously
described to be as a consequence of 25% of sympathetic activation and 75% of withdrawal
of parasympathetic activity [41], showing that heat affects more markedly the parasympa-
thetic component than the sympathetic component.
The strength of the current research is that an important external factor has been
defined when consecutive HRV measurements have to be carried out, defining how ambient
temperature can affect the assessment of an easy and cheap analysis method. Additionally,
the control of cardiac parasympathetic activity can be quantified simply with a heart-rate
band. Otherwise, some limitations are present, such as the sample size or the specificity of
the sample, which must be taken into account when interpreting the results.
5. Conclusions
Since the use of HRV has become more popular nowadays for several purposes, such
as clinical use, training workload assessment, or sympathetic-vagal modulation, it is im-
portant to take into account what kind of variables might influence HRV measurements.
The presented findings and investigation show great changes in HRV variables, suggest-
ing that different temperature conditions influence HRV parameters of time, frequency
domain, and Poincare plot variables. These finding are strongly coherent due to the heat
as a vasodilator. Thus, HRV measurements must always be carried out under the same
temperature conditions for the same person if several measurements have to be taken;
otherwise, the results might be altered. Moreover, the reduction of heart rate variability
due to the exposure to hot conditions appears to be produced mostly by a parasympathetic
withdrawal rather than a sympathetic activation.
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